SymBiosis Capital Partners, LLC

SymBiosis Capital Partners, LLC manages $109M in assets across 11 positions, with a concentrated portfolio comprising primarily of biotechnology and financial stocks. The fund's top holdings include Evolent Health Inc. (EVMN) at $21.9M, Verastem Inc. (VSTM) at $15.4M, and AmpliTech Group Inc. (AMPG) at $13.2M, collectively accounting for 46% of the portfolio. Notable positions also include Precigen Inc. (PGEN) at $12.5M and Innoviva Inc. (IVA) at $12.1M, demonstrating the manager's strategic focus on healthcare and growth-oriented investments. The fund's largest allocation is to EVMN, representing 20% of the total $109M in assets under management.

📌 Top Holdings